UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the quarterly period ended October 31, 2023
	For the quarterly period ended July 31, 2024
☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
	For the transition period from __________ to __________

000-54803

(Commission File Number)

ECO SCIENCE SOLUTIONS INC.

(Exact name of registrant as specified in its charter)

Nevada		46-4199032
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

300 S. El Camino Real #206 San Clemente, CA		92672
(Address of principal executive offices)		(Zip Code)

(833) 464-3726

(Registrant’s telephone number, including area code)

______________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act: None

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

None

N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☒
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of ~~December~~October 828, ~~2023~~2024, there were 52,957,572 shares of the registrant’s common stock outstanding.

ECO SCIENCE SOLUTIONS, INC.

TABLE OF CONTENTS

		Page
	PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements	3

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	4

Item 3.	Quantitative and Qualitative Disclosures About Market Risk	11

Item 4.	Controls and Procedures	11

	PART II – OTHER INFORMATION

Item 1.	Legal Proceedings	12

Item 1A.	Risk Factors	14

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	14

Item 3.	Defaults Upon Senior Securities	14

Item 4.	Mine Safety Disclosures	14

Item 5.	Other Information	14

Item 6.	Exhibits	15

	SIGNATURES	16

Table of Contents

PART I -- FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE UNAUDITED FINANCIAL STATEMENTS

(Unaudited)

		Page
Unaudited Condensed Consolidated Balance Sheets as of October 31, 2023 and January 31, 2023		F-1
Unaudited Condensed Consolidated Balance Sheets		F-1
Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended October 31, 2023 and 2022		F-2
Unaudited Condensed Consolidated Statements of Operations		F-2
Unaudited Condensed Consolidated Statements of Stockholders’ Deficit		F-3
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit)		F-3
Unaudited Condensed Consolidated Statements of Cash Flows for the three and nine months ended October 31, 2023 and 2022		F-4
Unaudited Condensed Consolidated Statements of Cash Flows		F-4
Notes to the Unaudited Condensed Consolidated Financial Statements		F-5 to F-17
Notes to Unaudited Condensed Consolidated Financial Statements		F-5

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

	October 31,2023			January 31,2023
	July 31,2024			January 31,2024
	(unaudited)			(audited)
ASSETS
Current assets
Cash	$	24,~~526~~745		$	~~526~~2,106
Prepaid expenses		-			14,000
Total current assets		4,745			2,106
Total current assets		2,526			14,526
Intangible asset		100,000			100,000
Intangible asset		100,000			-
TOTAL ASSETS	$	104,745		$	102,106
TOTAL ASSETS	$	102,526		$	14,526
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current liabilities
Accounts payable and accrued expenses	$	4,~~105~~441,~~532~~640		$	34,~~650~~196,~~587~~092
Related party payables		3,~~040~~277,~~473~~205			23,~~793~~118,~~945~~025
Notes payable, short-term, related party		3,~~521~~773,~~099~~861			3,~~171~~632,~~979~~242
Notes payable, current portion		2,960,118			2,610,118
Notes payable		2,960,118			2,960,118
Convertible note, net		1,656,213			1,656,213
Total current liabilities		1516,~~283~~109,~~435~~037			1315,~~882~~562,~~842~~690
Notes payable, net of current portion		-			350,000
Total liabilities		16,109,037			15,562,690
Total liabilities		15,283,435			14,232,842
Stockholders’ deficit
Preferred stock, $0.001 par, 50,000,000 shares authorized, none issued and outstanding		-			-
Preferred stock, $0.001 par, 50,000,000 shares authorized of which 1,000 shares are designated Series A Voting Preferred , none issued and outstanding		-			-
Common stock, $0.0001 par, 650,000,000 shares authorized, 53,957,572 shares issued and 52,957,572 shares outstanding		5,396			5,396
Treasury stock (1,000,000 shares issued at a cost of $0.0075 per share)		(7,500	)		(7,500	)
Additional paid in capital, common, and deferred compensation		62,166,104			62,166,104
Accumulated deficit		(7778,~~344~~168,~~909~~292	)		(7677,~~382~~624,~~316~~584	)
Total stockholders’ deficit		(1516,~~180~~004,~~909~~292	)		(1415,~~218~~460,~~316~~584	)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	$	~~102~~104,~~526~~745		$	14102,~~526~~106

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-1

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

	For the Three MonthsEnded October 31,						For the Nine MonthsEnded October 31,
	Three Months EndedJuly 31,						Six Months EndedJuly 31,
	2023			2022			2023			2022
	2024			2023			2024			2023
Revenue	$	-		$	-		$	-		$	-
Operating Expenses
Total revenue		-			-			-			-
Cost of revenue
Operating expenses:
Depreciation
Legal, accounting and audit fees		15,500			66,258			67,310			86,358
Legal, accounting and audit fees		22,500			42,500			108,858			94,000
Management and consulting fees		126,781			140,501			252,281			301,334
Management and consulting fees		140,500			189,500			441,833			578,500
Research, development, and promotion		82,087			123,696			165,959			222,242
Research, development, and promotion		107,603			218,059			321,253			572,182
Office supplies and other general expenses		5,556			11,370			20,437			22,885
Office supplies and other general expenses		5,609			12,034			37,087			50,767
Total operating expenses		229,924			341,825			505,987			632,819
Total operating expenses		276,212			462,093			909,031			1,295,449
Net operating loss		(229,924	)		(341,825	)		(505,987	)		(632,819	)
Net operating loss		(276,212	)		(462,093	)		(909,031	)		(1,295,449	)
Other income (expenses)
Interest income
Interest expense		(8,957	)		(9,807	)		(18,551	)		(19,296	)
Interest expense		(9,806	)		(9,808	)		(29,102	)		(29,104	)
Interest expense, related parties		(10,214	)		(8,254	)		(19,170	)		(15,987	)
Interest expense, related parties		(8,473	)		(7,046	)		(24,460	)		(19,713	)
Total other income (expenses)		(19,171	)		(18,061	)		(37,721	)		(35,283	)
Total other income (expenses)		(18,279	)		(16,854	)		(53,562	)		(48,817	)
Net loss	$	(249,095	)	$	(359,886	)	$	(543,708	)	$	(668,102	)
Net loss	$	(294,491	)	$	(478,947	)	$	(962,593	)	$	(1,344,266	)
Net loss per common share - basic and diluted	$	(0.00	)	$	(0.01	)	$	(0.01	)	$	(0.01	)
Net loss per common share - basic and diluted	$	(0.01	)	$	(0.01	)	$	(0.02	)	$	(0.03	)
Weighted average common shares outstanding - basic and diluted		52,957,572			52,957,572			52,957,572			52,957,572

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-2

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS’ DEFICIT

	Preferred Stock				Common Stock				Treasury Stock						AdditionalPaid in		Accumulated
	Shares		Amount		Shares		Amount		Shares			Amount			Capital		Deficit			Total
Balance, January 31, 2023		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(76,382,316	)	$	(14,218,316	)
Balance, January 31, 2024		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(77,624,584	)	$	(15,460,584	)
Net Loss		-		-		-		-		-			-			-		(~~308~~294,~~216~~613	)		(~~308~~294,~~216~~613	)
Balance, April 30, 2023		-		-		53,957,572		5,396		(1,000,000	)		(7,500	)		62,166,104		(76,690,532	)		(14,526,532	)
Balance, April 30, 2024		-		-		53,957,572		5,396		(1,000,000	)		(7,500	)		62,166,104		(77,919,197	)		(15,755,197	)
Net Loss																		(~~359~~249,~~886~~095	)		(~~359~~249,~~886~~095	)
Balance, July 31, 2023		-		-		53,957,572		5,396		(1,000,000	)		(7,500	)		62,166,104		(77,050,418	)		(14,886,418	)
Balance, July 31, 2024		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(78,168,292	)	$	(16,004,292	)
Net Loss																		(294,491	)		(294,491	)
Balance, October 31, 2023		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(77,344,909	)	$	(15,180,909	)

	Preferred Stock				Common Stock				Treasury Stock						AdditionalPaid in		Accumulated
	Shares		Amount		Shares		Amount		Shares			Amount			Capital		Deficit			Total
Balance, January 31, 2022		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(74,584,761	)	$	(12,420,761	)
Balance, January 31, 2023		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(76,382,316	)	$	(14,218,316	)
Net Loss		-		-		-		-		-			-			-		(~~435~~308,~~539~~216	)		(~~435~~308,~~539~~216	)
Balance, April 30, 2022		-		-		53,957,572		5,396		(1,000,000	)		(7,500	)		62,166,104		(75,020,300	)		(12,856,300	)
Balance, April 30, 2023		-		-		53,957,572		5,396		(1,000,000	)		(7,500	)		62,166,104		(76,690,532	)		(14,526,532	)
Net Loss																		(~~429~~359,~~780~~886	)		(~~429~~359,~~780~~886	)
Balance, July 31, 2022		-		-		53,957,572		5,396		(1,000,000	)		(7,500	)		62,166,104		(75,450,080	)		(13,286,080
Balance, July 31, 2023		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(77,050,418	)	$	(14,886,418	)
Net Loss																		(478,947	)		(478,947	)
Balance, October 31, 2022		-	$	-		53,957,572	$	5,396		(1,000,000	)	$	(7,500	)	$	62,166,104	$	(75,929,027	)	$	(13,765,027	)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-3

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

	For Nine Months endedOctober 31,
	For the Six Months ended July 31,
	2023			2022
	2024			2023
Cash flows from operating activities:
Net loss	$	(~~962~~543,~~593~~708	)	$	(1668,~~344,266~~102	)
Adjustments to reconcile net loss to net cash used in operating activities:
Changes in operating assets and liabilities:
Prepaid expenses		~~14,000~~-			(14,000	)
Increase (decrease) in accounts payable and accrued expenses		~~454~~245,~~945~~548			~~326~~297,~~066~~755
Increase (decrease) in related party payables		~~246~~159,~~528~~180			~~525~~168,~~353~~967
Net cash used in operating activities		(~~247~~138,~~120~~980	)		(~~506~~187,~~847~~380	)
Cash Flows from Investing Activities:
Acquisition of intangible asset		(100,000	)		-
Net cash used in investing activities		-			-
Net cash used in investing activities		(100,000	)		-
Cash flows from financing activities:
Advances from related party loans		~~349~~141,~~120~~619			~~507~~189,~~028~~235
Net cash provided by financing activities		~~349~~141,~~120~~619			~~507~~189,~~028~~235
Net decrease in cash		2,000			181
Net increase (decrease) in cash		2,639			1,855
Cash-beginning of period		~~526~~2,106			72526
Cash-end of period	$	24,~~526~~745		$	~~253~~2,381
SUPPLEMENTAL DISCLOSURES
Interest paid	$	-		$	-
Income taxes paid	$	-		$	-

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

F-4

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 1: NATURE OF BUSINESS AND CONTINUANCE OF OPERATIONS

Organization and nature of business

The Company was incorporated in the state of Nevada on December 8, 2009 under the name Pristine Solutions, Inc. On January 8, 2014, the Company changed its name from Pristine Solutions, Inc. to Eco Science Solutions, Inc.

On June 21, 2017, the Company acquired 100% of the shares of capital stock of Ga-Du Corporation (“Ga-Du”), at which time Ga-Du became a wholly owned subsidiary of the Company. Ga-Du offers a Financial Services Platform, as well as Inventory Control and Advisory Software Platforms, and Retail Inventory Control, bringing important enterprise technologies in-house and bringing ESSI an opportunity to expand the reach of its Herbo branding.

On January 28, 2021, the Company entered into an Asset Purchase Agreement with Haiku Holdings, LLC, wherein the Company purchased an enterprise software platform, coupling the Company’s consumer engagement applications and e-commerce platform to this proprietary enterprise accounting, inventory management, customer relationship management, and overall business operations, of which was developed by Haiku Holdings, LLC. The terms of the Asset Purchase Agreement are such that ESSI shall deliver to the Seller and/or it’s assigns an aggregate of 1,500,000 shares of its restricted common stock.

Going Concern

These unaudited condensed consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. As at ~~October~~July 31, ~~2023~~2024, the Company had a working capital deficit of $~~15.28~~16 million and an accumulated deficit of $~~77.34~~78 million. The continuation of the Company as a going concern is dependent upon the continued financial support from its ~~officers, directors and~~ shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company’s future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

Other factors

Factors which may impact the Company’s ongoing operations include inflation, the recent war in the Ukraine, ongoing supply chain issues as a result of the recent Covid-19 pandemic, climate change and others. These events may have serious adverse impact on domestic and foreign economies which may impact the Company’s operations as a result of a variety of factors including the potential for reduced consumer spending. The Company is unable to predict the ongoing impact of these factors on the Company’s financial operations.

The unaudited consolidated financial statements reflect all adjustments consisting of normal recurring adjustments, which, in the opinion of management, are necessary for a fair presentation of the results for the periods shown. The financial statements do not include any adjustments relating to the recoverability and classification of recorded assets, or the amounts of and classification of liabilities that might be necessary in the event the Company cannot continue in existence.

F-5

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

~~The~~This ~~accompanying~~summary ~~unaudited~~of ~~consolidated~~significant ~~financial statements have been prepared in accordance with generally accepted~~ accounting ~~principles~~policies ~~for~~is ~~interim~~presented ~~financial~~to ~~information~~assist ~~and~~in ~~with~~understanding the ~~instructions~~Company’s ~~for~~consolidated ~~Form~~financial ~~10-Q~~statements. These ~~and~~accounting ~~Article~~policies ~~210~~conform ~~8-03~~to ofaccounting ~~Regulation S-X. Accordingly~~principles, ~~they do not include all of the information and footnotes required by~~ generally accepted ~~accounting~~in ~~principles for complete financial statements. In~~ the ~~opinion~~United States of ~~management~~America, ~~all~~and ~~adjustments considered necessary for a fair presentation~~ have been ~~included. All~~consistently ~~such~~applied ~~adjustments~~in ~~are~~the preparation of athe ~~normal~~consolidated ~~recurring~~financial ~~nature~~statements. ~~Operating~~ Certain ~~results~~reclassifications ~~for~~have ~~the~~been ~~three~~made ~~and~~to ~~nine~~the ~~months~~prior ~~ended~~period’s ~~October~~consolidated ~~31,~~financial ~~2023,~~statements ~~are~~to ~~not~~conform ~~necessarily~~to ~~indicative of~~ the ~~results~~current ~~that~~period’s ~~may be expected for the fiscal year ending January 31, 2024~~presentation.

Principals of Consolidation

The condensed consolidated financial statements include the accounts of Eco Science Solutions, Inc. and its wholly-owned subsidiary, Ga-Du Corporation. All significant intercompany balances and transactions have been eliminated.

Use of Estimates

The preparation of financial statements in conformity with United States generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to long-lived assets and deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.

Property and Equipment

Property and equipment are recorded at cost. Depreciation and amortization on property and equipment are determined using the straight-line method over the three to five year estimated useful lives of the assets.

Technology, licensing rights and software (Intangible assets)

Technology, licensing rights and software are recorded at cost and capitalized. These costs are reviewed for impairment at a minimum of once per year or whenever events or changes in circumstances suggest a need for evaluation. During the three months ended April 30, 2023 the Company acquired certain commercial software (ref: Note 3) at a cost of $100,000 which amount has been capitalized. There is no impairment expense for the intangible assets in ~~three~~fiscal year ended January 31, 2024 and ~~nine~~in ~~months~~the six month period ended ~~October~~July 31, ~~2023~~2024. ~~and~~The ~~2022~~Company expects to amortize the software over an estimated useful life of 3 years once commercial sales begin.

Advertising and Marketing Costs

Advertising and marketing costs are expensed as incurred and were $0 during the three and nine months ended October 31, 2023 and were $0 and $2,550 during the three and nine months ended October 31, 2022, respectively. Advertising and marketing costs include costs incurred with the marketing of our Herbo Software such as ad placement and other internet marketing efforts.

F-6 Table of Contents

Revenue Recognition

Under ASC 606, the Company recognizes revenue from licensing agreements and contracts by applying the following steps: (1) identify the contract with a customer; (2) identify the performance obligations in the contract; (3) determine the transaction price; (4) allocate the transaction price to each performance obligation in the contract; and (5) recognize revenue when each performance obligation is satisfied. For the comparative periods, revenue has not been adjusted and continues to be reported under ASC 605 — Revenue Recognition. Under ASC 605, revenue is recognized when the following criteria are met: (1) persuasive evidence of an arrangement exists; (2) the performance of service has been rendered to a customer or delivery has occurred; (3) the amount of fee to be paid by a customer is fixed and determinable; and (4) the collectability of the fee is reasonably assured.

$0F-6 ~~has~~Table ~~been recognized as revenue in three and nine months ended October 31, 2023 and 2022. Revenue generated under enterprise software licenses will be recorded in accordance with the terms~~ of the individual Customer contracts. We expect license fees will be recorded on a monthly basis over the term of the contract, activation fees will be earned upon completion of set up and installation of the enterprise software, and customization and/or professional consulting services will be earned as rendered.Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

$0 has been recognized as revenue in the three- and six-month periods ended July 31, 2024, and 2023. Revenue generated under enterprise software licenses will be recorded in accordance with the terms of the individual Customer contracts. We expect license fees will be recorded on a monthly basis over the term of the contract, activation fees will be earned upon completion of set up and installation of the enterprise software, and customization and/or professional consulting services will be earned as rendered.

Cost of Revenue

Costs of revenue consist of the direct expenses incurred to generate revenue. Such costs are recorded as incurred. Our cost of revenue consists primarily of fees associated with the operational charges related to our Herbo enterprise software. During the three and ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024, and ~~2022~~2023 we incurred costs of sales of $0 with respect to the licensing of our Herbo software suite. In the case of revenue earned by our wholly owned subsidiary, proceeds allocated to our revenue interest are net of associated costs.

Stock-Based Compensation

The Company records stock-based compensation in accordance with ASC 718, Share-Based Payments, using the fair value method. All transactions in which goods or services are the consideration received for the issuance of equity instruments are accounted for based on the fair value of the consideration received or the fair value of the equity instrument issued, whichever is more reliably measurable. Equity instruments issued to employees and the cost of the services received as consideration are measured and recognized based on the fair value of the equity instruments issued.

Convertible Debt and Beneficial Conversion Features

The Company evaluates embedded conversion features within convertible debt under ASC 815 “Derivatives and Hedging” to determine whether the embedded conversion feature(s) should be bifurcated from the host instrument and accounted for as a derivative at fair value with changes in fair value recorded in earnings. If the conversion feature does not require derivative treatment under ASC 815, the instrument is evaluated under ASC 470-20 “Debt with Conversion and Other Options” for consideration of any beneficial conversion features.

Stock Settled Debt

In certain instances, the Company will issue convertible notes which contain a provision in which the price of the conversion feature is priced at a fixed discount to the trading price of the Company’s common shares as traded in the over-the-counter market. In these instances, the Company records a liability, in addition to the principal amount of the convertible note, as stock-settled debt for the fixed value transferred to the convertible note holder from the fixed discount conversion feature. As of ~~October~~July 31, ~~2023~~2024, and January 31, ~~2023~~2024, $248,432 for the value of the stock settled debt for certain convertible notes is included in the “Convertible note, net” account on the balance sheet. (see Note 6).

Basic and Diluted Net Income (Loss) Per Share

The Company computes net income (loss) per share in accordance with ASC 260, Earning per Share. ASC 260 requires presentation of both basic and diluted earnings per share (EPS) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common shareholders (numerator) by the weighted average number of shares outstanding (denominator) during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period using the treasury stock method and convertible preferred stock using the if-converted method. In computing Diluted EPS, the average stock price for the period is used in determining the number of shares assumed to be purchased from the exercise of stock options or warrants. Diluted EPS excludes all dilutive potential shares if their effect is anti-dilutive. Presently the Company’s shares are not listed for trading on an exchange and there is no market price for its common stock.

F-7

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Income Taxes

The Company follows ASC 740 – Income Taxes, which requires the use of the asset and liability method of accounting for income taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

Recently issued accounting pronouncements

~~In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40):~~ Accounting ~~for~~pronouncements not listed ~~Convertible~~below ~~Instruments~~were ~~and~~assessed ~~Contracts in an Entity’s Own Equity. The new guidance, among other things, simplifies the accounting for certain financial instruments with characteristics of liabilities~~ and ~~equity,~~determined including convertible instruments, and amends existing earnings-per-share (“EPS”) guidance by requiring that an entity use the if-converted method when calculating diluted EPS for convertible instruments. ASU 2020-06 is effective for public business entities that meet the definition of an SEC filer, excluding entities eligible to be not applicable ~~smaller~~or ~~reporting~~are ~~companies~~expected asto ~~defined~~have byminimal ~~the~~impact ~~SEC,~~on ~~for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities,~~ the ~~amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The~~ Company's ~~plans~~Consolidated toFinancial ~~adopt the new guidance effective January 1, 2024~~Statements.

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under current GAAP. ASU 2016-02 requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. ASU 2016-02 is effective for fiscal years beginning after December 15, 2021, using a modified retrospective approach and early adoption is permitted. The Company adopted ASU 2016-02 on February 1, 2022. The Company had no active leases at the time of adoption. The Company completed its assessment and concluded this update had no material impact on its consolidated financial statements and related disclosures.

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”). ASU 2016-13 provides guidance for recognizing credit losses on financial instruments based on an estimate of current expected credit losses model. The amendments are effective for fiscal years beginning after December 15, 2019. Recently, the FASB issued the final ASU to delay adoption for smaller reporting companies for fiscal years beginning after December 15, 2022. We adopted ASU 2016-13 on February 1, 2023 and it did not have a material impact on our consolidated financial statements and related disclosures.

In August 2020, the FASB issued ASU 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity. This ASU amends the guidance on convertible instruments and the derivatives scope exception for contracts in an entity’s own equity, and also improves and amends the related earnings per share guidance for both Subtopics. The ASU will be effective for smaller reporting companies for annual reporting periods beginning after December 15, 2023 and interim periods within those annual periods and early adoption is permitted. We are currently evaluating the impact of the new guidance on our consolidated financial statements.

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires a public entity to disclose significant segment expenses that are regularly provided to the chief operating decision maker ("CODM"), a description of other segment items by reportable segment, and an explanation of any additional measures the CODM uses in deciding how to allocate resources. The new guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, and early adoption is permitted. The guidance is to be applied on a retrospective basis, with such disclosures to be made in regard to all prior periods presented in the financial statements. The Company completed its assessment and concluded this update had no material impact on its consolidated financial statements.

F-8

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

In December 2023, the FASB issued ASU No. 2023-09, Income Taxes (Topic 470): Improvements to Income Tax Disclosures, which are designed to increase the transparency and decision-usefulness of income tax disclosures for financial statement users. The ASU follows investors indication and request for enhanced tax disclosures in order to better assess an entity’s operations, related tax risks, jurisdictional tax exposures, and increase transparency regarding tax information through improvements to tax disclosures, specifically rate reconciliation, income taxes paid, and unrecognized tax benefits and certain temporary differences. The new guidance is effective for fiscal years beginning after December 15, 2024 and interim periods within fiscal years beginning after December 15, 2025, and early adoption is permitted. The guidance is to be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the impact of adopting this ASU on our consolidated financial statements and disclosures.

NOTE 3 – INTANGIBLE ASSETS

On April 5, 2023, the Company and eXPO Financial Services LLC entered into a Software Acquisition Agreement (the “Software Agreement”) whereunder the Company has acquired from eXPO Financial Services all rights, title and interest to a computer program referred to as eXPO (electronic eXchange portal) for a total purchase price of $100,000 payable in installments over an eight-month period commencing April 15, 2023. A total of $14,000 reflected on the Company’s balance sheets at January 31, 2023 as prepaid deposits was immediately applied to the purchase price under the Software Agreement leaving a balance of $86,000 payable in installments over the eight-month term, which amount was paid in full as of January 31, 2024. The Company capitalized the software as of the date of the agreement as intangible assets and expects to amortize the software over an estimated useful life of 3 years once commercial sales begin.

NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

Accounts payable and accrued liabilities at ~~October~~July 31, ~~2023~~ 2024 and January 31, ~~2023~~2024 consist of the following:

	October 31,2023		January 31,2023
	July 31,2024		January 31,2024
Accounts payable	$	34,~~919~~206,~~291~~190	$	34,~~484~~004,~~448~~044
Interest payable		~~169~~198,~~241~~450		~~140~~179,~~139~~048
Accrued other expenses		1737,000		2613,000
	$	4,~~105~~441,~~532~~640	$	34,~~650~~196,~~587~~092

Included in accounts payable above is $17,000 payable in installments with respect to certain acquired software assets (Note 3 above).

F-8 Table of Contents

NOTE 5: NOTES PAYABLE

Notes payable consists of the following loans:

	October 31,2023		January 31,2023
	July 31,2024		January 31,2024
Note 1 in fiscal year 2017 each due in three months from issuance date	$	14,930	$	14,930
Note 2 in fiscal year 2017 due in three months from issuance date		50,000		50,000
Note 3 in fiscal year 2017, 2018 and 2019, each due in twelve months from issuance date		2,225,500		2,225,500
Note 4 in fiscal year 2017, each due in nine months from issuance date		305,266		305,266
Note 5 in fiscal year 2019 due in nine months from issuance date		14,422		14,422
Note 6 in fiscal year 2021 due in 3 years from issuance date		350,000		350,000
Total	$	2,960,118	$	2,960,118
Current portion	$	2,960,118	$	2,610,118
Debt, long term	$	-	$	350,000

~~Interest~~F-9 ~~expenses~~Table ~~recorded~~of ~~in three and nine months ended October 31, 2023 and 2022 is as follows:~~Contents

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	2023		2022		2023		2022
Interest expenses	$	6,209	$	6,208	$	18,426	$	18,426

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Interest expenses for above notes recorded in the three and six months ended July 31, 2024 and 2023 is as follows:

Three Months Ended

July 31,

Six Months Ended

July 31,

2024

2023

2024

2023

Interest expenses

6,209

6,211

12,284

12,217

Note 1:

During the fiscal year ended January 31, 2017, the Company received an accumulated amount of $14,930 from a third party. The notes bear interest at a rate of 1% per annum, and each note was due three months from issue date. As at July 31, 2024, the note remains unpaid and is in default.

Interest expenses recorded in ~~the~~ three and ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023 is as follows:

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Interest expenses	$	3837	$	3738	$	~~112~~74	$	~~111~~74

	October 31,2023		January 31,2023
	July 31,2024		January 31,2024
Interest payable	$	1,~~115~~226	$	1,~~003~~152
Note payable	$	14,930	$	14,930

Note 2:

During the fiscal year ended January 31, 2017, the Company received an amount of $50,000 from a third party. The note bears interest at a rate of 1% per annum and iswas due three months from issue date. As at January 31, 2018 the note became due and ~~remained~~remains unpaid and is in default.

Interest expenses recorded in the three and ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024, and ~~2022~~2023 is as follows:

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Interest expenses	$	126	$	126	$	~~374~~249	$	~~374~~248

	October 31,2023		January 31,2022
	July 31, 2024		January 31, 2024
Interest payable	$	3,~~502~~877	$	3,~~128~~628
Note payable	$	50,000	$	50,000

F-9 Table of Contents

Note 3:

During the fiscal year ended January 31, 2017, the Company received an amount of $225,000 from a third party. The note bears interest at a rate of 6% per annum and iswas due one year from issue date. During the fiscal year ended January 31, 2018, the Company received accumulated amounts of $1,842,500 from a third party. The notes bear interest at a rate of 6% per annum and each iswas due one year from issue date. During the fiscal year ended January 31, 2019, the Company received accumulated amounts of $1,420,500 from a third party. The notes bear interest at a rate of 6% per annum and each iswas due one year from the respective issue date.

OnF-10 ~~March~~Table ~~28, 2018 this third party purchased an additional $250,000 in notes from Rountree Consulting, a company controlled by our CEO, Mr. Michael Rountree. The purchased notes bear interest at a rate~~ of ~~1% per annum beginning on June 27, 2018 and are payable within thirty days’ notice of the Maturity Date.~~Contents

~~During~~ECO ~~the~~SCIENCE ~~fiscal year ended January 31~~SOLUTIONS, ~~2021 and 2020, the Company made cash payment of $5,000 and $7,500, respectively to the note~~INC.

OnNOTES ~~December~~TO 8,THE ~~2020,~~CONDENSED ~~the~~CONSOLIDATED ~~Company~~FINANCIAL cancelled One Million Five Hundred Thousand Dollars ($1,500,000) of debt of this notes under an order in the action captioned In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW. (Ref Note 13(1) - Contingencies).STATEMENTS

~~On January 31, 2021, the Company and Note holder enter into a consolidation of the principal sums of prior notes~~ (~~“Consolidated Note’~~UNAUDITED) that were entered into between the dates of January 1, 2017, and January 31, 2021. This Consolidated Note is non-interest bearing and pursuant to a court order in the action captioned In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW no interest accrued on any prior notes shall be payable to the note holder. The term of this Consolidated Note will be one year, and one day, and due on February 1, 2022. However, no payments shall be made toward this Note without approval from the Board of Directors.

		October 31,2023				January 31,2023
Note payable		$	2,225,500			$	2,225,500

On March 28, 2018 this third party purchased an additional $250,000 in notes from Rountree Consulting, a company controlled by our CEO, Mr. Michael Rountree. The purchased notes bear interest at a rate of 1% per annum beginning on June 27, 2018 and were payable within thirty days’ notice of the Maturity Date.

During the fiscal year ended January 31, 2021 and 2020, the Company made cash payments of $5,000 and $7,500, respectively to the note.

On December 8, 2020, the Company cancelled One Million Five Hundred Thousand Dollars ($1,500,000) of debt owing on these notes under an order in the action captioned In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW. (Ref Note 13(1) - Contingencies).

On January 31, 2021, the Company and Note holder entered into a consolidation of the principal sums of prior notes (“Consolidated Note’) entered into between the dates of January 1, 2017, and January 31, 2021. This Consolidated Note is non-interest bearing and pursuant to a court order in the action captioned In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW no interest accrued on any prior notes shall be payable to the note holder. The term of this Consolidated Note was one year, and one day, and due on February 1, 2022. However, no payments shall be made toward this Note without approval from the Board of Directors. The Consolidated Note is currently in default

July 31,

2024

January 31,

2024

Note payable

2,225,500

Note 4:

During the year ended January 31, 2019, the Company received $305,266 in total proceeds from a third party. The notes bear interest at a rate of 1% per annum, and ~~are~~were each due nine months from issue date. The notes remain unpaid and are in default.

Interest expenses recorded in the three and ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023 is as follows:

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Interest expenses	$	716	$	~~716~~717	$	21,~~126~~417	$	21,~~126~~410

	October 31,2023		January 31,2023
	July 31,2024		January 31,2024
Interest payable	$	1417,~~968~~102	$	1215,~~842~~685
Note payable	$	305,266	$	305,266

Note 5:

On September 12, 2018, the Company received $14,422 from a third party. The notes bear interest at a rate of 1% per annum, and ~~are~~were due nine months from issue date. The notes remain unpaid and are in default.

F-1011 Table of Contents

~~Interest~~ECO ~~expenses~~SCIENCE ~~recorded in three and nine months ended October 31~~SOLUTIONS, ~~2023 and 2022 is as follows:~~INC.

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	2023		2022		2023		2022
Interest expenses	$	36	$	36	$	108	$	108

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

	October 31,2023		January 31,2023
Interest payable	$	741	$	633
Note payable	$	14,422	$	14,422

(UNAUDITED)

Interest expenses recorded in the three and six months ended July 31, 2024, and 2023 is as follows:

Three Months Ended

July 31,

Six Months Ended

July 31,

2024

2023

2024

2023

Interest expenses

July 31,

2024

January 31,

2024

Interest payable

849

777

Note payable

14,422

Note 6:

On December 8, 2020, the Company entered into a Promissory Note in the amount of $350,000 with Robbins LLP, pursuant to the Order and Judgment in the settlement of a lawsuit entitled In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW-WRP (D. Haw.). The note bears interest at a rate of 6% per annum, and due in three years from issue date. The note remains unpaid and is in default.

Interest expenses recorded in the three and ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024, and ~~2022~~2023 is as follows:

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Interest expenses	$	5,293	$	5,293	$	1510,~~706~~471	$	1510,~~707~~413

	October 31,2023		January 31,2023
	July 31,2024		January 31,2024
Interest payable	$	6076,~~813~~578	$	4566,107
Note payable	$	350,000	$	350,000

NOTE 6: CONVERTIBLE NOTE PAYABLE

During October 2017, the Company entered into a convertible note for a total of $1,407,781 bearing interest at 1% per annum, beginning on November 1, 2017, and payable each 120 days as to any outstanding balance. On November 1, 2018, the Maturity Date, the Lender ~~has~~had the option to:

(a)	Convert the $1,407,781 Debt, plus accrued interest, into shares of Eco Science Solutions, Inc. Common Stock, at the rate of 15% discount to the closing price on the day of lender’s conversion request, per share; or

(b)	Lender may demand full payment of $1,407,781 or any unpaid balance of the original debt, plus accrued interest from the Company.

The note has a conversion feature with a fixed discount to the trading price of the underlying common stock and therefore, the potential for the convertible note to become stock settled debt. The note allows the holder to convert the debt to shares of common stock at a 15% discount to the closing price of the Company’s common stock at the lender’s request. Therefore, upon review of the applicable guidance contained in ~~FASB~~ASU ~~Codification 2730~~No.15 ~~through 2730.17~~2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, given that the note has a principal balance of $1,407,781, the holder will always be able to convert the note into $1,656,213 of principal. The debt discount determined as of the date of the note of $248,432 was amortized over the one-year term of the convertible note payable.

F-1112 Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

As at the date of this report, the Lender has not made a demand for payment and the note is in default.

At ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024, convertible notes payable consisted of the following:

	October 31,2023		January 31,2023
	July 31,2024		January 31,2024
Principal amount	$	1,407,781	$	1,407,781
Liability on stock settled debt		248,432		248,432
Convertible notes payable, net	$	1,656,213	$	1,656,213

Interest expenses recorded in the three and ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024, and ~~2022~~2023 is as follows:

	For the Three MonthsEnded October 31,				For the Nine MonthsEnded October 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Interest expenses	$	3,~~597~~598	$	3,598	$	107,~~676~~117	$	107,~~676~~079

	October 31,2023		January 31,2022
	July 31,2024		January 31,2024
Interest payable	$	8596,~~679~~394	$	7589,~~003~~277

NOTE 7: RELATED PARTY TRANSACTIONS

As of ~~October~~July 31, ~~2023~~2024, and January 31, ~~2023~~2024, related parties and former related parties are due a total of $67,~~561~~051,~~572~~066 and $56,~~965~~750,~~924~~267, respectively:

	October 31,2023		January 31,2023
	July 31,2024		January 31,2023
Related party payables (1)(2)(3)(4)(5)(6)	$	3,~~040~~277,~~473~~205	$	23,~~793~~118,~~945~~025
Notes payable (1)(3)(4)		3,~~521~~773,~~099~~861		3,~~171~~632,~~979~~242
Total related party transactions	$	67,~~561~~051,~~572~~066	$	56,~~965~~750,~~924~~267

Services provided from related parties and former related parties:

	Three Months EndedOctober 31,				Nine Months EndedOctober 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Mr. Jeffery Taylor (1)(a)	$	-	$	~~28,750~~-	$	~~9,584~~-	$	869,~~250~~584
Mr. Don Lee Taylor (1)(a)		-		~~26,250~~-		~~8,750~~-		788,750
Ms. Meredith Rountree (2b)		-		22,500		-		67,500
Ms. Jennifer Taylor (2)(a)		-		-		-		-
Ms. Jennifer Taylor (2a)		-		9,000		-		27,000
Ms. Meredith Rountree (2)(b)		-		-		-		-
Mr. Michael Rountree (3)(a)		62,500		62,500		~~187~~125,~~500~~000		~~187~~125,~~500~~000
	$	62,500	$	~~149~~62,~~000~~500	$	~~205~~125,~~834~~000	$	~~447~~143,~~000~~334

F-1213 Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

Interest expenses due to related parties and former related parties:

	Three Months EndedOctober 31,				Nine Months EndedOctober 31,
	Three Months EndedJuly 31,				Six Months EndedJuly 31,
	2023		2022		2023		2022
	2024		2023		2024		2023
Mr. Don Lee Taylor (1)(b)	$	33	$	33	$	9865	$	9865
Mr. Michael Rountree (3)(b)		8,~~012~~901		67,~~585~~792		2317,~~091~~406		1815,~~344~~079
Mr. Lewis (4)		~~428~~429		~~428~~429		~~1,271~~848		~~1,271~~843
	$	89,~~473~~363	$	78,~~046~~254	$	2418,~~460~~319	$	1915,~~713~~987

(1) Effective December 17, 2015, Mr. Jeffery Taylor was appointed to serve as Chief Executive Officer and President of the Company and Mr. Don Lee Taylor was appointed to serve as Chief Financial Officer of the Company. On January 11, 2016, Mr. Jeffery Taylor was appointed Secretary and to the Board of Directors and Mr. Don Taylor was appointed to the Board of Directors. On December 8, 2020, Jeffery Taylor resigned his position as Chairman of the Board, Don Taylor resigned his positions as CFO and a Member of the Board of Directors and accepted a role as Director of Festivals. On January 28, 2021, the Board of Directors accepted the resignation of Jeffery Taylor as Chief Executive Officer, effective as of January 31, 2021. On January 17, 2023, the Company accepted the resignation of Mr. Don Taylor as Director of Festivals and Mr. Jeffery Taylor as Director, President and Secretary. Concurrent with the resignations of Mr. Jeffery Taylor and Mr. Don Taylor the Company agreed to accrue fees under their respective employment agreements through the end of February 2023, after which the Company ~~shall~~incurred ~~incur~~ no further expense.

(a) Employment agreements with Mr. Jeffery Taylor and Mr. Don Lee Taylor

On December 21, 2015, the Company entered into employment agreements with Mr. Jeffery Taylor and Mr. Don Lee Taylor for a period of 24 months, ~~where~~ after the contract may be renewed in one-year terms at the election of both parties. Jeffery Taylor shall receive an annual gross salary of $115,000 and Don Lee Taylor shall receive an annual gross salary of $105,000 payable in equal instalments on the last day of each calendar month and which may be accrued until such time as the Company has sufficient cash flow to settle amounts payable. Further under the terms of the respective agreements all inventions, innovations, improvements, know-how, plans, development, methods, designs, analyses, specifications, software, drawings, reports and all similar or related information (whether or not patentable or reduced to practice) which relate to any of the Company’s actual or proposed business activities and which are created, designed or conceived, developed or made by the Executive during the Executive’s past or future employment by the Company or any Affiliates, or any predecessor thereof (“Work Product”), belong to the Company, or its Affiliates, as applicable. The contracts were formally terminated with an effective date of February 28, 2023, for each of Mr. Don and Mr. Jeffery Taylor.

During the ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024, the company didn’t make any cash payments to both. During the fiscal years ended January 31, 2024, and ~~2022~~2023, the ~~company~~Company paid $15,000 and $6790,~~500~~000, respectively, to Mr. Jeffery Taylor and $0 and $56,000, respectively, to Mr. Don Lee Taylor. OnAs ~~October~~at July 31, ~~2023~~2024, there was a total of $44,721 owing to Mr. Jeffery Taylor (January 31, ~~2023~~2024 - $5044,~~137~~721) and $426,450 to Mr. Don Lee Taylor (January 31, ~~2023~~2024 - $~~417~~426,~~700~~450), respectively, in accrued and unpaid salary under the terms of their employment agreements.

F-14

Table of Contents

(b) Note payable

On February 17, 2016, the Company issued promissory notes to Mr. Jeffery Taylor, CEO, in the amount of $17,500 and to Mr. Don Lee Taylor, CFO, in the amount of $17,500, respectively. The notes bear interest at a rate of 1% per annum, maturing on August 17, 2016. During the fiscal year ended January 31, 2017, the ~~company~~Company repaid $2,500 to Mr. Jeffery Taylor and $2,500 to Mr. Don Lee Taylor. During the fiscal year ended January 31, 2019, the ~~company~~Company repaid $5,000 to Mr. Jeffery Taylor and $2,000 to Mr. Don Lee Taylor. During the fiscal year ended January 31, 2020, the ~~company~~Company repaid $10,000 to Mr. Jeffery Taylor and $0 to Mr. Don Lee Taylor. As at ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024, there was a total of $0 owing to Mr. Jeffery Taylor, and $13,000 to Mr. Don Lee Taylor.

(2a)

For the three and ~~nine~~six months ended ~~October~~July 31, 2024, and 2023, the Company was invoiced a total of $0 as consulting services by Ms. Jennifer Taylor, sister of certain of the Company’s former officers and directors. ~~For~~As ~~three and nine months ended October 31, 2022, the Company was invoiced a total~~ of ~~$9,000~~July ~~and $27,000, respectively. On October~~ 31, ~~2023~~2024 and January 31, ~~2023~~2024, there was a total of $166,000 in accrued and unpaid consulting fees.

(2b)

For the three and ~~nine~~six months ended ~~October~~July 31, 2024, and 2023, the Company was invoiced a total of $0, as consulting services included in research and development by Ms. Meredith Rountree, sister of the Company’s Chief Executive Officer. ~~For~~As ~~three and nine months ended October 31, 2022, the Company was invoiced a total~~ of ~~$22,500~~July ~~and 67,500, respectively On October~~ 31, ~~2023~~2024 and January 31, ~~2023~~2024, there was a total of $161,250 in accrued and unpaid consulting fees.

F(3) (a) Employment agreement/Executive Employment Agreement with Michael Rountree On June 21, 2017, the Company entered into an employment agreement with Michael Rountree whereby Mr. Rountree agreed to serve as the Company’s Chief Operating Officer for two years unless terminated earlier in accordance with the agreement. During his period of employment, Mr. Rountree was to receive a base salary at an annual rate of $120,000. The Board shall review the Base Salary on an annual basis and may, but is not required to, make upward adjustments from time to time. On December 8, 2020, Michael Rountree was appointed interim CFO and Treasurer. On January 28, 2021, as amended March 1, 2021, the Company entered into an Executive Employment Agreement (“Agreement”), effective January 31, 2021, with Michael Rountree, the Company’s current Chief Operating Officer. Michael will serve as the Chief Executive Officer, as well as the Chief Financial Officer. The term of the Agreement is for three years. Mr. Rountree shall be entitled to the amount of $250,000 per year (the “Base Salary”), which amount shall accrue, until such time as the Company has sufficient resources to remit regular payments. The Agreement provides for certain additional terms and conditions based upon the Company achieving certain financial thresholds. The Executive’s base salary may not be decreased during the Employment Term other than as part of an across-13the-board ~~Table~~salary reduction that applies in the same manner to all senior executives of ~~Contents~~the Company, or if the duties of the Executive are materially changed. We recorded $62,500 as fees in each quarter ended July 31, 2024, and 2023 under the terms of this agreement, all of which remains unpaid. As at July 31, 2024 there was a total of $1,315,000 (January 31, 2024 - $1,190,000) in accrued and unpaid salary under the terms of the employment agreement. In addition, during the six months ended July 31, 2024, Mr. Rountree funded a total accumulated amount of $15,862 for the Company’s expenses. As of July 31, 2024, Mr. Rountree was owed total expenses of $310,609 (January 31, 2024 - $294,474).

(3) (a) Employment agreement/Executive Employment Agreement with Michael Rountree On June 21, 2017, the Company entered into an employment agreement with Michael Rountree whereby Mr. Rountree agreed to serve as the Company’s Chief Operating Officer for two years unless terminated earlier in accordance with the agreement. During his period of employment, Mr. Rountree has a base salary at an annual rate of $120,000. The Board shall review the Base Salary on an annual basis and may, but is not required to, make upward adjustments from time to time. On December 8, 2020, Michael Rountree was appointed interim CFO and Treasurer. On January 28, 2021, as amended March 1, 2021, the Company entered into an Executive Employment Agreement (“Agreement”), effective January 31, 2021, with Michael Rountree, the Company’s current Chief Operating Officer. Michael will serve as the Chief Executive Officer, as well as the Chief Financial Officer. The term of the Agreement is for three years. Mr. Rountree shall be entitled to the amount of $250,000 per year (the “Base Salary”), which amount shall accrue, until such time as the Company has sufficient resources to remit regular payments. The Agreement provides for certain additional terms and conditions based upon the Company achieving certain financial thresholds. The Executive’s base salary may not be decreased during the Employment Term other than as part of an across-the-board salary reduction that applies in the same manner to all senior executives of the Company, or if the duties of the Executive are materially changed. We recorded $62,500 and $187,500 as fees in the three and nine months ended October 31, 2023 and 2022 under the terms of this agreement, all of which remains unpaid. As at October 31, 2023 there was a total of $1,127,500 (January 31, 2023 - $940,000) in accrued and unpaid salary under the terms of the employment agreement. In addition, during the nine months ended October 31, 2023 and 2022, Mr. Rountree funded a total accumulated amount of $31,235 and $36,757, respectively, for the Company’s expenses. As at October 31, 2023, Mr. Rountree was owed total expenses of $288,571 (January 31, 2023 - $257,336).

(b) Note payable with Rountree Consulting, a company controlled by Mr. Rountree

During the year ended January 31, 2019, the Company issued promissory notes to Rountree Consulting in the accumulated amount of $379,319.

During the fiscal year ended January 31, 2020, the Company issued promissory notes to Rountree Consulting in the accumulated amount of $805,901.

During the fiscal year ended January 31, 2021, the Company issued promissory notes to Rountree Consulting in the accumulated amount of $395,325. On January 28, 2021, the Company entered into a Debt Settlement and Share Purchase Agreement with Rountree Consulting, Inc., owned by The Rountree Trust, wherein Rountree Consulting, Inc. ~~has~~a ~~agreed~~was toissued ~~accept~~ 500,000 unregistered, restricted shares of the Company’s common stock at a price of US $0.50 per share in settlement of a portion, in the amount of $250,000 of the total debt owed to Rountree Consulting, Inc. by the Company.

F-15

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

During the fiscal year ended January 31, 2022, the Company issued promissory notes to Rountree Consulting in the accumulated amount of $1,033,131.

During the fiscal year ended January 31, 2023, the Company issued promissory notes to Rountree Consulting in the accumulated amount of $694,874.

During the ~~nine~~fiscal ~~months~~year ended ~~October~~January 31, ~~2023~~2024, the Company issued promissory notes to Rountree Consulting in the accumulated amount of $~~349~~460,~~120~~263.

~~F-14~~During ~~Table~~the six months ended July 31, 2024, the Company issued promissory notes to Rountree Consulting in the accumulated amount of ~~Contents~~$141,619.

These notes bear interest at a rate of 1% per annum, each is due nine months from issue date. Several of the aforementioned notes are currently in default.

(4) (a) Employment agreement with L. John Lewis On June 21, 2017, Ga-Du entered into an employment agreement with L. John Lewis whereby Mr. Lewis accepted employment as Chief Executive Officer of Ga-Du for two years unless terminated earlier in accordance with the agreement. During his period of employment, Mr. Lewis has a base salary at an annual rate of $120,000. The employment agreement was not renewed on expiry. OnAs ~~October~~of July 31, ~~2023~~2024 there was a total of $240,000 in accrued and unpaid salary under the terms of the employment agreement (January 31, ~~2023~~2024 - $240,000).

(b) Note payable

During the three months ended April 30, 2018, Mr. Lewis paid $175,000 to third parties on behalf of the Company which amount ~~has~~was ~~been~~ recorded in Accounts payable – related parties.

On July 31, 2018, the Company issued promissory notes to Mr. Lewis to convert the payable amount to a note payable in the amount of $170,000. The notes bear interest at a rate of 1% per annum, each iswas due nine ~~month~~months from the issue date and all notes are currently in default.

(5)	On June 21, 2017, Ga-Du Corporation, a wholly owned subsidiary of Eco Science Solutions Inc. entered into an employment agreement with S. Randall Oveson whereby Mr. Oveson accepted employment as Chief Operating Officer of Ga-Du for two years unless terminated earlier in accordance with the agreement. During his period of employment, Mr. Oveson ~~has~~was to receive a base salary at an annual rate of $120,000. The employment agreement was not renewed on expiry. OnAs ~~October~~at July 31, ~~2023~~2024 and January 31, ~~2023~~2024 there was a total of $240,000 in accrued and unpaid salary under the terms of the employment agreement.
(6)	On June 21, 2017, Ga-Du entered into a consulting agreement with Andy Tucker, whereby Mr. Tucker will provide services to the Cannabis industry under development by the Company, as well as act as an advisor to various State regulators concerning the Cannabis industry for two years unless terminated earlier in accordance with the agreement. During the period of the agreement, Mr. Tucker ~~has~~was to receive a base salary at an annual rate of $120,000. The employment agreement was not renewed on expiry. As at ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024 there was a total of $240,000 in accrued and unpaid salary under the terms of the employment agreement. Mr. Tucker holds approximately 10.29% of the Company’s issued and outstanding shares.
(7)	On January 28, 2021, the Company entered into an Indemnification Agreement with each of Michael Rountree, A. Carl Mudd and S. Randall Oveson where under the Company will indemnify each of the aforementioned parties in their respective positions as officers and/or directors, to the fullest extent permitted by applicable law, so that hethey will serve, and continue to serve, the Company free from undue concern that hethey will not be so indemnified.

F-16

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

NOTE 8: CAPITAL STOCK

Common Stock

The total number of authorized shares of common stock that may be issued by the Company is 650,000,000 shares with a par value of $0.0001.

As of ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024, there were 53,957,572 shares issued including 1,000,000 shares of treasury stock, and 52,957,572 shares outstanding.

~~F-15~~Preferred ~~Table of Contents~~Shares

The total number of authorized shares of preferred stock that may be issued by the Company is 50,000,000 shares with a par value of $0.001.

Series A Voting Preferred Shares

On January 11, 2016, the Company’s Board of Directors (the “Board”) authorized the creation of 1,000 shares of Series A Voting Preferred Stock. The holder of the shares of the Series A Voting Preferred Stock has the right to vote those shares of the Series A Voting Preferred Stock regarding any matter or action that is required to be submitted to the shareholders of the Company for approval. The vote of each share of the Series A Voting Preferred Stock is equal to and counted as 10 times the votes of all of the shares of the Company’s (i) common stock, and (ii) other voting preferred stock issued and outstanding on the date of each and every vote or consent of the shareholders of the Company regarding each and every matter submitted to the shareholders of the Company for approval. The Series A Voting Preferred Stock will not be convertible into Common Stock.

As of ~~October~~January 31, ~~2023~~2024, and January 31, 2023, no Series A Voting Preferred Shares were issued.

NOTE 9: COMMITMENTS

(da) On July 21, 2017, we entered into a Sublease commencing August 1, 2017, and terminating the earlier of (a) March 31, 2020, or (b) the date ~~this~~the sublease is terminated by sub landlord upon the occurrence of an event of default, the sublease ~~covers~~covered a total of 6,120 square feet of office space. Monthly base rent for the period September 1, 2017 to July 31, 2018 iswas $14,535, and the first month of rent iswas free of charge. In the second year the monthly base rent ~~increases~~increased to $15,173. In the third year the monthly base rent ~~increases~~increased to $15,810. The Company ~~has~~ remitted a security deposit in the amount of $15,810 in respect of this sublease. The Company ~~has~~ passed on recording the deferred rent relative to the one free month of rent contained within the lease as it ~~has~~was ~~been~~ determined to be immaterial. During the period ended April 30, 2018, the Company accrued rent in respect to this sublease for the months of March and April 2018 including applicable operating costs. Subsequent to October 31, 2018, the Company ~~has~~ abandoned the space without payment or further accruals, and the lease ~~has~~was ~~been~~ effectively terminated. After deduction of the Security deposit, a balance of $21,051 remains due and payable at ~~October~~July 31 ,2024 ~~2023~~ and January 31, ~~2023~~2024.

(eb) The Company has entered into verbal agreements with Take2L, an arm’s length third party, to develop and service our current technology platform in consideration for certain fees as invoiced monthly. On September 1, 2018, Take2L invoiced $350,000 to the Company in respect of the ongoing development of software to support our platform. AtAs ~~April~~of ~~30, 2023 and~~ January 31, 2023, Take2L had invoiced the Company a cumulative total of $1,328,810, including the original $350,000, of which at ~~April~~January 3031, 2023 the Company ~~has~~had paid a total of $327,500 towards the outstanding balance payable. In each of the ~~three~~fiscal ~~and~~years ~~nine months~~ ended ~~October~~January 31, ~~2023~~2024, ~~the Company paid $0. In each of the three~~ and ~~nine~~2023 ~~months ended October 31, 2022~~ the Company paid $~~30,000,~~0 and $60117,~~000 respectively~~500. As at ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024 an amount of $1,001,310 remained due and payable to Take 2L in respect to invoices issued for services rendered. The Company has been unable to settle these invoices as they have come due. Take 2L has had a long working relationship with our Chief Operating Officer, Mr. Rountree, ~~and~~ with regard to other ~~business~~businesses; Take 2L has no relationship with the Company other than as a provider of services to the Company and does not hold any shares in the Company. Take 2L has continued to provide the Company with essential services during the shortfall in funds to meet operational overhead as it comes due and it is expected these accounts will be settled in full as soon as resources become available.

F-1617 Table of Contents

(fc) As a result of an Order and Final Judgment signed by the Honorable Leslie Kobayashi and filed with the United States District Court for the District of Hawaii on December 3, 2020 with respect to the action captioned In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW-WRP (D. Haw.), the Company and Plaintiffs undertook certain actions including the cancelation of certain shareholdings by various parties, the cancelation of certain debt by certain Plaintiffs, the settlement of certain legal fees by way of issuance of shares of common stock, the reconstitution of the board and the appointment of an Ombudsman, for the Company for a term of four (4) years from the settlement date. Among other commitments, the Company agreed as resources are available to implement certain Governance Reforms in two phases, including but not limited to the following:

- Appointment of two new independent directors to the Company’s board of directors - Appointment of an Ombudsman - Binding of Directors’ and Officers’ Insurance - Creation of a Board level governance committee - Adoption of written corporate guidelines and a code of ethics - Creation of an audit committee - Creation of an investor relations officer - Retention of In-house Counsel - Appointment of several additional positions including a CAO and enhancement of Board independence; - Implementation of additional policies and practices.

Further, the Company ~~undertakes~~undertook to dedicate not less than 15% of such revenue, debt raised, or equity infused (regardless of source, but apart from and in addition to any personal contributions toward Company operations made by current officers, directors and employees) toward achieving the agreed-upon objectives and implementation and maintenance of the Governance Reforms. Upon attainment of $10,000,000 in cash collected from revenue, debt, or equity, the Company shall dedicate a minimum of 18% of such revenue, debt raised, or equity infused (apart from and in addition to any personal contributions toward Company operations made by current officers, directors and employees). These minimum contributions may be adjusted upward as deemed necessary and appropriate by the Ombudsman.

(gd) On December 23, 2020, the Company entered into a Board Advisory Agreement inby which Mr. Carl Mudd agreed to serve as the Chairman of the Board of Directors of the Company (the “Board”) and as Ombudsman for the Company pursuant to both Rule 53 of the Federal Rules of Civil Procedure, and to the Order and Judgment in the settlement of a lawsuit entitled In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW-WRP (D. Haw.) (the “Stipulation of Order”). As consideration for his service, in addition to receiving two million five hundred thousand (2,500,000) restricted shares of the Company’s common stock, he will receive an advisory fee of Ten Thousand Dollars ($10,000) per month, commencing December 24, 2020. Half of the monthly advisory fee ($5,000) must be paid to Mr. Mudd, while the other half of the advisory fee may be accrued on a monthly basis until the Company has closed a bona fide third-party debt and/or equity financing of at least eight hundred thousand dollars ($800,000). As at ~~October~~April 3130, ~~2023~~2024 Mr. Mudd was owed $~~340~~400,000 which is comprised of $30,000 for each of the three months ended April 30, 2023, July 31, 2023 and October 31, 2023, $120,000 for each of the years ended January 2023 and 2022 and $10,000 for fiscal year 2021. The term of this Agreement shall be four (4) years or as set forth in the Stipulation of Order. This Agreement may be terminated by either party upon thirty (30) days’ notice for material breach. If the caveat emptor symbol affixed to the Company is not removed by the OTC Marketplace by February 28, 2021, that shall constitute a material breach under this Section. In addition, this Agreement shall terminate in the event of the resignation of Advisor from the Board.

F-18

Table of Contents

ECO SCIENCE SOLUTIONS, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

The term of this Agreement is four (4) years or as set forth in the Stipulation of Order. This Agreement may be terminated by either party upon thirty (30) days’ notice for material breach. If the caveat emptor symbol affixed to the Company is not removed by the OTC Marketplace by February 28, 2021, that shall constitute a material breach under this Section. In addition, this Agreement shall terminate in the event of the resignation of Advisor from the Board.

NOTE 10: SUBSEQUENT EVENTS

The Company has evaluated subsequent events from the balance sheet date through the date that the financial statements were issued and determined that there are no additional subsequent events to disclose.

F-1719 Table of Contents

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward Looking Statements

This quarterly report contains forward-looking statements. These statements relate to future events or the Company’s future financial performance. In some cases, forward-looking statements can be identified by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors” that may cause the Company’s or its industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.

Although the Company believes that the expectations reflected in the forward-looking statements are reasonable, it cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, the Company does not intend to update any of the forward-looking statements to conform these statements to actual results.

The Company’s unaudited financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with the Company’s financial statements and the related notes that appear elsewhere in this quarterly report.

The following discussion contains forward-looking statements that reflect the Company’s plans, estimates and beliefs. The Company’s actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include but are not limited to those discussed below and elsewhere in this quarterly report. All adjustments necessary for a fair statement of the results for the interim periods have been made, and all adjustments are of a normal recurring nature.

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States Dollars and all references to “common shares” refer to the common shares in the Company’s capital stock.

As used in this quarterly report, the terms “we”, “us”, “our” and “ESSI” mean Eco Science Solutions, Inc. unless otherwise indicated. “Ga-Du” refers to our wholly owned subsidiary Ga-Du Corporation.

Description of Business

The Company was incorporated in the state of Nevada on December 8, 2009, under the name Pristine Solutions, Inc. On February 14, 2014, the Company changed its name to Eco Science Solutions, Inc. (The “Company” or “Eco Science”). The Company’s principal executive office is located at 300 S. El Camino Real #206 San Clemente, CA 92672. The Company’s telephone number is 833-GoHerbo (833 464-3726). The Company’s website is www.useherbo.com.

The Company intends to continue developing and operating as a technology solutions provider servicing businesses that have complex financial accounting, inventory management, and sales tracking in both regulated and non-regulated verticals. We have developed and launched our cloud-based ERP platform (“Herbo”) and financial services platform (“HerboPay”) to support the unique end-to-end business requirements of regulated, cash-intensive industries that include, but are not limited to: cannabis, gaming, firearms and ammunition; and non-regulated, but highly complex industries such as oil and gas. We continue to identify and prioritize multi-billion vertical industries that are fractionalized and have an operational need to leverage technology solutions such as Herbo to bring visibility, traceability and viability to their business operations.

Table of Contents

We will continue to enhance our enterprise initiatives focused on developing technologies that build upon our existing, proprietary financial accounting platform, coupled with data analytics, to help businesses to be more effective in their abilities to connect, market, and transact to businesses and sell directly to consumers.

Eco Science Solutions, Inc. is currently pursuing business opportunities in farming, extraction, manufacturing and distribution in both the cannabis and CBD hemp industries. We seek to provide a 360-degree ecosystem that connects B2B (business-to-business), B2C (business-to-consumer) and B2G (business-to-government) segments together through technology offerings that include: business location directory, localized digital communications between consumers and business operators, social networking, e-commerce connected inventory management / selection, payment facilitation and cash management. This unique end-to-end offering enables traditional B2B manufacturers with opportunities to directly engage and sell to consumers seamlessly and efficiently.

* Eco Science Solutions, Inc. is not in the business of growing, manufacturing, or distributing cannabis.

The Company’s common stock symbol “ESSI” was revoked on October 6, 2022, due to delinquent SEC filings. The Company ~~intends~~is toin ~~file~~the process of filing a Form 15c2-11 in order to ~~have~~allow its stock to resume trading on the ~~OTC~~OTCMarkets site as soon as practicable; the Company will request the symbol ESSI.

We currently have ~~very~~no ~~limited~~ revenue and are actively seeking users of our software; Mr. Rountree is pursuing opportunities with state legislature in states where cannabis is legal. Additionally, Mr. Rountree is actively searching out businesses that would benefit from using the Herbo ERP and HerboPay financial software.

Results of Operations

Overview of Current Operations

~~Results~~Three ~~of Operations for the three and nine~~ months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023

As at October 31, 2023 and January 31, 2023, the Company had $2,526 and $526 in cash, prepaid expenses of $0 and $14,000 for total current assets of $2,526 and $14,526. Prepaid expenses at January 31, 2023 relate to amounts paid as an advance with respect to the acquisition of certain third party software assets acquired during the three months ended April 30, 2023 for a total purchase price of $100,000. We reflect intangible assets in respect to these software assets of $100,000 and $0 at October 31, 2023 and January 31, 2023. Total liabilities at October 31, 2023 and January 31, 2023 were $15,283,435 and $14,232,842 respectively. The Company has insufficient funds to meet its ongoing operations and is currently funded through loans and advances from our CEO and CFO, Mr., Michael Rountree.

	For the Three Months Ended July 31,
	2024			2023
Revenue	$	-		$	-

Operating Expenses
Cost of revenue
Depreciation
Legal, accounting and audit fees		15,500			66,258
Management and consulting fees		126,781			140,501
Research, development, and promotion		82,087			123,696
Office supplies and other general expenses		5,556			11,370
Total operating expenses		229,924			341,825

Net operating loss		(229,924	)		(341,825	)

Other income (expenses)
Interest income
Interest expense		(8,957	)		(9,807	)
Interest expense, related parties		(10,214	)		(8,254	)
Total other income (expenses)		(19,171	)		(18,061	)

Net loss	$	(294,095	)	$	(359,886	)

Three months ended October 31, 2023 and 2022

	For the Three MonthsEnded October 31,
	2023			2022
Revenue	$	-		$	-
Operating Expenses
Cost of revenue
Depreciation
Legal, accounting and audit fees		22,500			42,500
Management and consulting fees		140,500			189,500
Research, development, and promotion		107,603			218,059
Office supplies and other general expenses		5,609			12,034
Total operating expenses		276,212			462,093
Net operating loss		(276,212	)		(462,093	)
Other income (expenses)
Interest income
Interest expense		(9,806	)		(9,808	)
Interest expense, related parties		(8,473	)		(7,046	)
Total other income (expenses)		(18,279	)		(16,854	)
Net loss	$	(294,491	)	$	(478,947	)

Table of Contents

During each of the three months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023, the Company has generated $0 in total revenue.

During the three months ended ~~October~~July 31, ~~2023~~2024, and ~~2022~~2023, the Company incurred total operating expenses of $~~276~~229,~~212~~924 and $~~462~~341,~~093,~~825 respectively. During the three months ended ~~October~~July 31, ~~2023~~2024, ~~and 2022~~ management and consulting fees reflected a decrease from $~~189~~140,~~500~~501 (~~2022~~2023) to $~~140~~126,~~500~~781 (~~2023~~2024) due to a reduction in consulting fees related to investor relations. Amounts incurred for accounting, audit and legal fees ~~increased~~decreased period over period and totaled $2215,500 (~~2023~~2024) and $4266,~~500~~258 (~~2022~~2023), respectively, with the decrease predominantly relating to ana decrease in fees incurred ~~from~~for ~~our~~audit ~~independent~~related ~~public~~services ~~registered~~in ~~accounting~~the ~~firm~~current as3 wemonths ~~did~~ended ~~not~~July ~~publish quarterly reports for certain periods in fiscal year 2023~~31, ~~but rather included such reports in our Form 10 Registration filing~~2024. During the three months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023 research and development fees incurred were $~~107~~82,~~603~~087 and $~~218~~123,~~059~~696 respectively as the ~~company~~Company continued to conclude upgrades to its software suite. Fees declined over the comparative periods as a result of completion of certain stages of development and the concurrent reduction to required man hours allocated to research and development in the current three-month period ended ~~October~~July 31, ~~2023~~2024. Other operating and general and administrative expenses decreased period over period from $1211,~~034~~370 in the three months ended ~~October~~July 31, ~~2022~~2023, to $5,~~609~~556 for the three months ended ~~October~~July 31, ~~2023~~2024, ~~relative~~mainly due to ~~amounts~~a ~~paid~~reduction ~~for~~in ~~reporting~~stock ~~costs,~~transfer ~~rent,~~fees ~~travel~~ and ~~other~~travel ~~costs~~expenses.

~~Currently~~The Company arecorded ~~significant~~cumulative ~~portion~~interest ~~of our total operating~~ expenses ~~are~~of ~~from~~$19,171 ~~management~~ and ~~consultant~~$18,061 ~~fees. Several costs have been incurred~~ in ~~order~~respect ~~to bring our regulatory product to market, including programming~~ of ~~technology,~~certain ~~build~~convertible ~~out~~notes ofand ~~needed~~other ~~infrastructure~~loan ~~for customers including sand-boxes~~agreements, ~~build~~respectively ~~out~~during ~~of training materials (like~~ the ~~Herbo~~three ~~University~~months onended ~~our~~July ~~website )~~31, ~~generation of marketing materials~~2024, ~~as well as efforts to meet,~~ and ~~present, our product before various regulators in various jurisdictions, both foreign and domestic~~2023.

The ~~Company~~ ~~recorded~~net ~~cumulative~~loss ~~interest~~for ~~expense~~the ofthree ~~$18,279~~months ~~and~~ended ~~$16~~July 31,~~854~~ in2024 ~~respect~~was of$249,095, ~~certain~~as ~~convertible~~compared ~~notes~~to ~~and other loan agreements~~$359,886 ~~respectively~~in ~~during~~ the three months ended ~~October~~July 31, 2023 ~~and 2022~~.

~~The~~Six ~~net loss for the three~~ months ended ~~October~~July 31, ~~2023~~2024 ~~$294,491,~~and ~~as compared to $478,947 in the three months ended October 31, 2022.~~2023

Nine months ended October 31, 2023 and 2022

	For the Six Months Ended July 31,
	2024			2023
Revenue	$	-		$	-

Operating Expenses
Cost of revenue
Depreciation
Legal, accounting and audit fees		67,310			86,358
Management and consulting fees		252,281			301,334
Research, development, and promotion		165,959			222,242
Office supplies and other general expenses		20,437			22,885
Total operating expenses		505,987			632,819

Net operating loss		(505,987	)		(632,819	)

Other income (expenses)
Interest income
Interest expense		(18,551	)		(19,296	)
Interest expense, related parties		(19,170	)		(15,987	)
Total other income (expenses)		(37,721	)		(35,283	)

Net loss	$	(543,708	)	$	(668,102	)

	For the Nine MonthsEnded October 31,
	2023			2022
Revenue	$	-		$	-
Operating Expenses
Cost of revenue
Depreciation
Legal, accounting and audit fees		108,858			94,000
Management and consulting fees		441,833			578,500
Research, development, and promotion		321,253			572,182
Office supplies and other general expenses		37,087			50,767
Total operating expenses		909,031			1,295,449
Net operating loss		(909,031	)		(1,295,449	)
Other income (expenses)
Interest income
Interest expense		(29,102	)		(29,104	)
Interest expense, related parties		(24,460	)		(19,713	)
Total other income (expenses)		(53,562	)		(48,817	)
Net loss	$	(962,593	)	$	(1,344,266	)

During each of the six months ended July 31, 2024, and 2023, the Company has generated $0 in total revenue.

During the six months ended July 31, 2024, and 2023, the Company incurred total operating expenses of $505.987 and $632,819 respectively. During the six months ended July 31, 2024 management and consulting fees reflected a decrease from $301,334 (2023) to $252,281 (2024) mainly due to a reduction in investor relations fees from $98,000 to $67,281 and a reduction in management fees of $18,333. Amounts incurred for accounting, audit and legal fees decreased period over period and totaled $67,310 (2024) and $86,358 (2023), respectively, with the decrease predominantly relating to a decrease in fees incurred from our independent public registered accounting firm as we did not publish quarterly reports for certain periods in fiscal year 2023, but rather included such reports in our Form 10 Registration filing. During the six months ended July 31, 2024 and 2023 research and development fees incurred were $165,959 and $222,242 respectively as the Company continued to conclude upgrades to its software suite. Fees declined over the comparative periods as a result of completion of certain stages of development and the concurrent reduction to required man hours allocated to research and development in the current six-month period ended July 31, 2024. Other operating and general and administrative expenses decreased slightly period over period from $22,885 in the six months ended July 31, 2023 to $20,437 for the six months ended July 31, 2024 mainly due to a reduction in stock transfer fees.

Table of Contents

~~During~~The Company ~~each~~recorded ofcumulative ~~the~~interest ~~nine~~expenses ~~months~~of ~~ended~~$37,721 ~~October~~and 31$35,283 ~~2023~~in respect of certain convertible notes and ~~2022~~other loan agreements, respectively during the ~~Company~~six ~~has~~months ~~generated~~ended $0July in31, ~~total~~2024, ~~revenue~~and 2023.

~~During~~The ~~the~~net ~~nine~~loss months ended October 31, 2023 and 2022, the Company incurred total operating expenses of $909,031 and $1,295,449, respectively. During the nine months ended October 31, 2023 and 2022 management and consulting fees reflected a decrease from $578,500 (2022) to $441,833 (2023). Amounts incurred for ~~accounting, audit and legal fees increased period over period and totaled $108,858 (2023) and $94,000 (2022), respectively, with~~ the ~~increase~~six ~~to fees recorded in the current period predominantly relating to an increase in fees incurred from our independent public registered accounting firm. During the nine~~ months ended ~~October~~July 31, ~~2023~~2024 ~~and~~was ~~2022 research and development fees incurred were~~ $~~321~~543,~~253 and $572~~708,~~182~~ ~~respectively~~ as ~~the~~compared ~~company continued~~ to conclude upgrades to its software suite. Fees declined over the comparative periods as a result of completion of certain stages of development and the concurrent reduction to required man hours allocated to research and development in the current nine-month period ended October 31, 2023. Other operating and general and administrative expenses decreased period over period from $50668,~~767~~102 in the ~~nine~~six months ended ~~October~~July 31, ~~2022 to $37,087 for the nine months ended October 31,~~ 2023 ~~relative to amounts paid for reporting costs, rent, travel and other costs~~.

Currently a significant portion of our total operating expenses are from management and consultant fees. Several costs have been incurred in order to bring our regulatory product to market, including programming of technology, build out of needed infrastructure for customers including sand-boxes, build out of training materials including educational and instructional videos which are housed within our website, generation of marketing materials, as well as efforts to meet, and present, our product before various regulators in various jurisdictions, both foreign and domestic.

~~The Company~~Statements ~~recorded cumulative interest expenses~~ of ~~$53,562~~ ~~and~~Cash ~~$48,817~~Flows infor ~~respect of certain convertible notes and other loan agreements, respectively during~~ the ~~nine~~Six ~~months~~Months ended ~~October~~July 31, ~~2023~~2024 and ~~2022.~~2023

The Company used net ~~loss~~cash ~~for~~in operations of $138,980 and $187,380 respectively during the ~~nine~~six-month ~~months~~periods ended ~~October~~July 31, 2024 and 2023 due to a decrease in accounts payable and accrued expenses from $~~962~~297,~~593,~~755 as(2023) ~~compared~~ to $1245,~~344~~548 (2024),~~266~~ and a decrease in ~~the~~related ~~nine~~party ~~months~~payables ~~ended~~from ~~October~~$168,967 31(2023) to $159,180. ~~2022~~The Company received cash from financing activities of $141,619 (2024) and $189,235 (2023), as a result of proceeds from related party loans.

Statements of Cash Flows for the Nine Months ended October 31, 2023 and 2022

The Company used net cash in operations of $247,120 and $506,847 respectively during the nine-month periods ended October 31, 2023 and 2022, recorded $100,000 as net cash used for investing activities in the nine months ended October 31, 2023 compared to $0 in cash used in investing activities in the nine months ended October 31, 2022 and received cash from financing activities of $349,120 (2023) and $507,028 (2022), as a result of proceeds from related party loans.

Plan of Operation

The Company changed the focus of its business at the close of fiscal 2016 to operate in the eco-friendly technology sector using social media sites and offering apps to generate advertising revenues and download fees, and to development certain enterprise software for the cannabis industry. During fiscal 2017 the Company laid the groundwork for income generation from these services by investing in ongoing development of its applications, websites and visibility in both the local and global market. The Company has invested heavily in advertising to allow its applications and ecommerce website visibility on a global stage. During fiscal 2018 we further added to our business portfolio with the acquisition of Ga-Du corporation and its in house software offerings.

7In ~~Table~~each of ~~Contents~~the years ended January 31, 2021 through 2024, and in the six months ended July 31, 2024 the Company has continued to incur costs to expand and develop its Herbo software suite of offerings. The Company’s need for ongoing capital by way of loans, sale of equity and/or convertible notes is expected to continue during the current fiscal year until we can establish revenues from operations to cover all operational overhead. We have also had to rely heavily on loans from related parties in our most recently completed fiscal years as we work to have our shares returned for quotation on the OTC Markets. There are no assurances additional capital will be available to the Company on acceptable terms or that this equity line will be available to us when needed.

Fiscal 2020 brought our first revenues from our acquired Herbo enterprise software and we expect to see increasing revenues from this suite of services as we focus on marketing to a larger more focused client base. In each of the years ended January 31, 2021 through 2023, and in the nine months ended October 31, 2023 the Company has continued to incur costs to expand and develop its Herbo software suite of offerings. The Company’s need for ongoing capital by way of loans, sale of equity and/or convertible notes is expected to continue during the current fiscal year until we can establish revenues from operations to cover all operational overhead. We have also had to rely heavily on loans from related parties in our most recently completed fiscal years as we work to have our shares returned for quotation on the OTC Markets. There are no assurances additional capital will be available to the Company on acceptable terms or that this equity line will be available to us when needed.

Future funding could result in potentially dilutive issuances of equity securities, the incurrence of debt, contingent liabilities and/or amortization expenses related to goodwill and other intangible assets, which could materially adversely affect the Company’s business, results of operations and financial condition. Any future funding might require the Company to obtain additional equity or debt financing, which might not be available on terms favorable to the Company, or at all, and such financing, if available, might be dilutive.

Table of Contents

Going Concern

These unaudited consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenues to date and has never paid any dividends and is unlikely to pay dividends or generate significant earnings in the immediate or foreseeable future. As at ~~October~~July 31, ~~2023~~2024, the Company had a working capital deficit of $~~15.28~~16 million and an accumulated deficit of $~~77.34~~78 million. The continuation of the Company as a going concern is dependent upon the continued financial support from its ~~officers, directors and~~ shareholders, the ability to raise equity or debt financing, and the attainment of profitable operations from the Company’s future business. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern.

Other factors

Liquidity and Capital Resources

As at ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024, the Company had $24,~~526~~745 and $~~526~~2,106 respectively, in cash, ~~prepaid expenses of $0 and $14,000~~ for total current assets of $24,~~526~~745 and $142,~~526~~106. ~~Prepaid~~As ~~expenses~~ at ~~January~~July 31, ~~2023~~2024 ~~relate~~and toJanuary ~~amounts~~31, ~~paid~~2024, ~~as an advance with respect to~~ the ~~acquisition~~Company ofhad ~~certain~~intangible ~~third party software~~ assets ~~acquired during the three months ended April 30, 2023 for a total purchase price~~ of $100,000. At each Weof ~~reflect~~July ~~intangible~~31, ~~assets~~2024 inand ~~respect~~January to31, ~~these~~2024, ~~software~~the Company had total assets of $~~100~~104,~~000~~745 and $~~0 at October 31~~102,106 ~~2023 and January 31, 2023~~respectively. Total liabilities at ~~October~~July 31, ~~2023~~2024 and January 31, ~~2023~~2024 were $1516,~~283~~109,~~435~~037 and $1415,~~232~~562,~~842~~690 respectively. The Company has insufficient funds to meet its ongoing operations and is currently funded through loans and advances from our CEO and CFO, Mr., Michael Rountree.

8The ~~Table~~Company has limited financial resources available outside loans from its officers and directors and funds it has previously obtained through use of ~~Contents~~convertible notes and loans from related parties. There can be no guarantee the Company will continue to receive proceeds from loans, related party advances or convertible notes sufficient to meet its ongoing operational overheads as we continue to implement our business plan. While we generated modest revenue in fiscal 2022, we did not report any revenue in fiscal 2024 or in the three months ended April 30, 2024 as we continued to enhance our software suite and we do not yet have resources to meet our operational shortfalls. Without realization of additional capital, it would be unlikely for the Company to continue as a going concern. As noted, additional working capital may be sought through additional debt or equity private placements, additional notes payable to banks or related parties (officers, directors or stockholders), or from other available funding sources at market rates of interest, or a combination of these. The ability to raise necessary financing will depend on many factors, including the nature and prospects of any business to be acquired and the economic and market conditions prevailing at the time financing is sought. During the most recently completed fiscal year management has obtained additional funding with success, however there is no guarantee we will be able to continue to obtain financing if and when required. The current economic downturn may make it difficult to find new capital sources for the Company should they be required.

The Company has limited financial resources available outside loans from its officers and directors and funds it has previously obtained through use of convertible notes and loans from related parties. There can be no guarantee the Company will continue to receive proceeds from loans, related party advances or convertible notes sufficient to meet its ongoing operational overheads as we continue to implement our business plan. While we generated modest revenue in fiscal 2022, we did not report any revenue in fiscal 2023 or in the nine months ended October 31, 2023 as we continued to enhance our software suite and we do not yet have resources to meet our operational shortfalls. Without realization of additional capital, it would be unlikely for the Company to continue as a going concern. As noted, additional working capital may be sought through additional debt or equity private placements, additional notes payable to banks or related parties (officers, directors or stockholders), or from other available funding sources at market rates of interest, or a combination of these. The ability to raise necessary financing will depend on many factors, including the nature and prospects of any business to be acquired and the economic and market conditions prevailing at the time financing is sought. During the most recently completed fiscal year management has obtained additional funding with success, however there is no guarantee we will be able to continue to obtain financing if and when required. The current economic downturn may make it difficult to find new capital sources for the Company should they be required.

Future Financings

We anticipate continuing to rely on related party and third-party loans and equity sales of our common shares and/or shares for services rendered in order to continue to fund our business operations in the event of ongoing operational shortfalls. Issuances of additional shares will result in dilution to our existing shareholders. There is no assurance that we will achieve any of additional sales of our equity securities or arrange for debt or other financing to fund our research and development activities.

Contractual Obligations

As a “smaller reporting company”, the Company is not required to provide tabular disclosure obligations.

Off-Balance Sheet Arrangements

The Company has no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on the Company’s financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

Table of Contents

Critical Accounting Policies

The discussion and analysis of the Company’s financial condition and results of operations are based upon the Company’s consolidated audited financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States of America. Preparing financial statements requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by management’s application of accounting policies. The Company believes that understanding the basis and nature of the estimates and assumptions involved with the following aspects of the Company’s financial statements is critical to an understanding of its consolidated financial statements.

Use of Estimates

9 Table of Contents

Advertising and Marketing Costs

Advertising and marketing costs are expensed as incurred and were $0 during the three and nine months ended October 31, 2023 and advertising and marketing costs are expensed as incurred and were $0 and $2,550 during the three and nine months ended October 31, 2022, respectively. Advertising and marketing costs include costs incurred with the marketing of our Herbo Software such as ad placement and other internet marketing efforts.

Revenue Recognition

$0 has been recognized as revenue in ~~three~~six ~~and nine~~ months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023. Revenue generated under enterprise software licenses will be recorded in accordance with the terms of the individual Customer contracts. We expect license fees will be recorded on a monthly basis over the term of the contract, activation fees will be earned upon completion of set up and installation of the enterprise software, and customization and/or professional consulting services will be earned as rendered.

Cost of Revenue

Costs of revenue consist of the direct expenses incurred to generate revenue. Such costs are recorded as incurred. Our cost of revenue consists primarily of fees associated with the operational charges related to our Herbo enterprise software. During the ~~three~~six ~~and nine~~ months ended ~~October~~July 31, ~~2023~~2024 and ~~2022~~2023 we ~~incurred~~did not incur costs of sales ~~of $0~~ with respect to the licensing of our Herbo software suite. In the case of revenue earned by our wholly owned subsidiary, proceeds allocated to our revenue interest are net of associated costs.

Stock-Based Compensation

Table of Contents

Convertible Debt and Beneficial Conversion Features

Stock Settled Debt

10 Table of Contents

Income Taxes

Recently issued accounting pronouncements

~~In August 2020, the FASB issued ASU 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40):~~ Accounting ~~for~~pronouncements not listed ~~Convertible~~below ~~Instruments~~were ~~and~~assessed ~~Contracts in an Entity’s Own Equity. The new guidance, among other things, simplifies the accounting for certain financial instruments with characteristics of liabilities~~ and ~~equity,~~determined including convertible instruments, and amends existing earnings-per-share (“EPS”) guidance by requiring that an entity use the if-converted method when calculating diluted EPS for convertible instruments. ASU 2020-06 is effective for public business entities that meet the definition of an SEC filer, excluding entities eligible to be not applicable ~~smaller~~or ~~reporting~~are ~~companies~~expected asto ~~defined~~have byminimal ~~the~~impact ~~SEC,~~on ~~for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. For all other entities,~~ the ~~amendments are effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. The~~ Company’s ~~plans~~Consolidated toFinancial ~~adopt the new guidance effective January 1, 2024~~Statements.

Table of Contents

In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires a public entity to disclose significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), a description of other segment items by reportable segment, and an explanation of any additional measures the CODM uses in deciding how to allocate resources. The new guidance is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024, and early adoption is permitted. The guidance is to be applied on a retrospective basis, with such disclosures to be made in regard to all prior periods presented in the financial statements. The Company completed its assessment and concluded this update had no material impact on its consolidated financial statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is a smaller reporting Company as defined by Rule 12b-2 of the Securities Act of 1934 and we are not required to provide the information under this item.

ITEM 4. CONTROLS AND PROCEDURES

Disclosure Controls and Procedures

Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of ~~October~~July 31, ~~2020~~2024. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms. Such officer also confirmed that there was no change in our internal control over financial reporting during the ~~nine-~~six month period ended ~~October~~July 31, ~~2023~~2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Changes in Internal Control over Financial Reporting

There have been no changes in the Company’s internal controls over financial reporting that occurred during the ~~nine~~six months ended ~~October~~July 31, ~~2023~~2024 that have materially, or are reasonably likely to materially, affect the Company’s internal controls over financial reporting.

Table of Contents

PART II

ITEM 1. LEGAL PROCEEDINGS

On October 20, 2017, a purported shareholder of the Company, Mr. Ian Bell, filed a verified stockholder derivative complaint against the Individual Defendants in the United States District Court for the District of Hawaii (the “First Hawaii Complaint”). On January 11, 2018, a purported shareholder of the Company, Mr. Marc D’ Annunzio, filed a verified stockholder derivative complaint against the Individual Defendants in the United States District Court for the District of Hawaii (the “Second Hawaii Complaint”). On February 9, 2018, the Hawaii federal court consolidated the First Hawaii Complaint and the Second Hawaii Complaint (the “Consolidated Hawaii Action”). On December 10, 2018, plaintiffs in the Consolidated Hawaii Action filed their amended complaint (the “Amended Hawaii Complaint”). The Company is identified as a nominal defendant, against which no claims are plead. The Amended Hawaii Complaint arises out of alleged materially false and misleading statements or omissions from SEC filings and/or public statements by or on behalf of the Company. The Amended Hawaii Complaint asserts claims on behalf of the Company for breach of fiduciary duty against the Taylors and Mr. Lewis and Mr. Oveson, for aiding and abetting breaches of fiduciary duties against Mr. Lewis and Mr. Oveson, for aiding and abetting breaches of fiduciary duties against Mr. Giguiere, for waste of corporate assets against the Individual Defendants, and for unjust enrichment against the Individual Defendants. The Amended Hawaii Complaint seeks damages for the alleged breaches of fiduciary duties, aiding and abetting, waste and unjust enrichment, demands restitution and disgorgement and requests an order directing the Company and all individual defendants to take all necessary actions to reform and improve the Company’s corporate governance in order to avoid any alleged future harm to the Company.

On September 21, 2020, the United States District Court for the District of Hawaii issued an order in the action captioned In re Eco Science Solutions, Inc. Shareholder Derivative Litigation Lead Civil No. 1:17-cv-00530-LEW-WRP (D. Haw.), preliminarily approving a proposed settlement (the “Settlement”) as set forth in a Stipulation of Settlement dated September 21, 2020 (the “Stipulation”), by and among (i) plaintiffs Mr. Ian Bell and Mr. Marc D’ Annunzio, individually and derivatively on behalf of Eco Science Solutions Inc. (the “ESSI or the Company”); (ii) certain of the Company’s current and former officers, directors and consultants; and (iii) the Company. Pursuant to the Court’s Preliminary Approval Order, a hearing was held on November 17, 2020, before the Honorable Leslie Kobayashi, in the United States District Court for the District of Hawaii and approved terms of Settlement for an Order issued December 3, 2020, including the following:

	(1)	The resignation of Jeffery Taylor as Chairman of the Board to the Company; and Don Taylor as Chief Financial Officer and a member of the Board of Directors;
	(2)	Appointment of Carl Mudd or such individual with similar background and qualifications to serve as Ombudsman and as Chairman of the Board.
	(3)	The following shareholders have been ordered to return a cumulative total of 3,500,000 shares of the Company’s common stock to treasury for cancellation, as set out herein: (a) Gannon Giguiere – 1,500,000 shares; (b) Jeffery Taylor – 750,000 shares; (c) Don Taylor – 750,000 shares; (d) L John Lewis – 250,000 shares; and (e) S Randall Oveson – 250,000 Shares
	(4)	The Company shall issue 1,400,000 restricted common stock to the law firm of Robbins, LLP, as consideration for attorney fees;
	(5)	The Company shall enter into a Promissory Note with the law firm of Robbins, LLC for in the amount of Three Hundred Fifty Thousand Dollars ($350,000) with respect to legal fees incurred, note bearing interest at a rate of six (6%) percent per annum calculated monthly with all interest and principal due and payable no later than three (3) years from the date of the final Settlement approval;
	(6)	Debt in the amount of One Million Five Hundred Thousand Dollars ($1,500,000) held by Phenix Ventures LLC, a company controlled by Gannon Giguiere, shall be immediately forgiven and canceled.

12Additionally, ~~Table~~the Settlement called for 15% of ~~Contents~~the Company’s revenue and/or any financing raised by the Company be dedicated toward achieving the objectives, implementation and maintenance of the Governance Reforms.

~~Additionally,~~All of the ~~Settlement~~above-listed ~~called~~items ~~for~~in the Order issued by the Honorable Leslie Kobayashi have been implemented except putting aside 15% of the Company’s revenue and/ or financing as the Company has not yet generated any revenue of substance, nor have they secured any financing ~~raised~~to bydate. Mr. Rountree continues to fund the Company bewith ~~dedicated~~his ~~toward~~personal ~~achieving~~funds and once the ~~objectives~~Company begins generating revenue or secures financing, ~~implementation~~15% ~~and~~will ~~maintenance~~be ofput aside. In addition to the aforementioned stipulations under the Settlement, Governance Reforms. were set forth, in pertinent part, inter alia, as follows:

~~All~~12 ofTable ~~the above-listed items in the Order issued by the Honorable Leslie Kobayashi have been implemented except putting aside 15%~~ of the Company’s revenue and or financing as the Company has not yet generated any revenue of substance, nor have they secured any financing to date. Mr. Rountree continues to fund the Company with his personal funds and once the Company begins generating revenue or secures financing, 15% will be put aside. Mr. Mudd, continues to act as the Ombudsman and oversees the required government reforms. Contents

Each of the reforms are subject to the judgement of the Ombudsman, Mr. A Carl Mudd and/or the reconstituted Board, and based on the availability of funding.

In1. ~~addition~~The topurchase ~~the~~of ~~aforementioned~~Directors’ ~~stipulations~~and ~~under~~Officers’ ~~the~~Insurance ~~Settlement~~2. Appointment of two new, independent Directors 3. Creation of a board-level Governance ~~Reforms~~Committee ~~were~~4. ~~set~~Adoption ~~forth~~of Written Corporate Governance Guidelines and Code of Ethics 5. Creation of an Audit Committee 6. Enhanced Board Independence 7. Termination of existing compensation plans – compensation plans that existed at the time of the Order have been terminated. 8. Immediate cessation of current and future business dealings with third party stock promoters – there is not now, nor has there been dealings with third party stock promoters. 9. Maintain the Company’s website – the Company’s website is maintained and updated 10. Creation of an Investor Relations Officer – we will engage an investor relations officer once the company begins generating enough revenue so that Mr. Rountree is not financing the filings required by a public company 11. Engage In-House and General Counsel – the Company has an in-house ~~pertinent~~counsel ~~part, inter~~and ~~alia,~~ will engage general counsel as ~~follows:~~necessary 12. Appointment of a Chief Accounting Officer – Mr. Rountree is our Chief Financial Officer 13. Create a written Whistleblower Policy 14. Adopt a Clawback Policy 15. Adopt enhanced conflicts policies and practices 16. Establish documentation of Policies and Financial Reporting Checklist 17. Annually assess the adequacy of the Company’s internal controls 18. Provide continuing director education and employee compliance training 19. Establish board oversight of Company’s expenditures

Numbers 1. ~~The~~through ~~purchase~~6 ofto ~~Directors’~~date ~~and~~have ~~Officers’~~not ~~Insurance~~been 2.implemented ~~Appointment~~as ofthere ~~two~~has ~~new,~~been ~~independent~~no ~~Directors~~revenue 3.generated ~~Creation~~and ofcurrently athe ~~board-level~~Company ~~Governance~~only ~~Committee~~has 4.one ~~Adoption of Written Corporate Governance Guidelines and Code of Ethics 5~~employee. To ~~Creation~~date, ~~of an Audit Committee 6~~Mr. ~~Enhanced~~Rountree ~~Board~~is ~~Independence~~funding 7.the ~~Termination~~Company ofand ~~existing~~there ~~compensation~~aren’t ~~plans~~enough –funds ~~compensation~~to ~~plans~~implement ~~that~~all ~~existed~~of at the ~~time~~requirements of the ~~Order have been terminated~~Stipulation. 8 Mr. ~~Immediate~~Mudd ~~cessation~~continues ofto ~~current~~monitor ~~and future business dealings with third party stock promoters – there is not now, nor has there been dealings with third party stock promoters. 10. Maintain~~ the ~~Company’s~~progress ~~website~~of – the Company~~’s website is maintained and updated 11~~. Numbers ~~Creation~~14 ofthrough an19 ~~Investor~~have ~~Relations~~not ~~Officer~~yet –been weimplemented; ~~will~~with ~~engage~~regard anto ~~investor~~number ~~relations~~20, ~~officer once~~ the ~~company~~Board ~~begins~~discusses ~~generating~~with ~~enough revenue so that~~ Mr. Rountree ~~is not financing~~ the ~~filings~~expenses ~~required~~incurred by ~~a public company 12. Engage In-House and General Counsel –~~ the Company ~~has~~at anboard ~~in-house counsel and will engage general counsel as necessary 13~~meetings. Agreement ~~Appointment~~calls offor athe ~~Chief~~above ~~Accounting~~to ~~Officer~~be –completed ~~Mr.~~within ~~Rountree~~four isyears; ~~our~~however, ~~Chief~~the ~~Financial~~implementation ~~Officer~~of ~~14.~~each ~~Create~~remains aat ~~written~~the ~~Whistleblower~~discretion, ~~Policy 15. Adopt a Clawback Policy 16. Adopt enhanced conflicts policies~~ and ~~practices~~subject ~~17.~~to ~~Establish~~the ~~documentation~~judgement, of ~~Policies~~Mr. ~~and Financial Reporting Checklist 18~~Mudd. In ~~Annually assess~~ the ~~adequacy~~event ofthat the Company’s ~~internal~~does ~~controls~~not ~~19.~~begin ~~Provide~~to ~~continuing~~generate ~~director~~income, ~~education~~or ~~and~~secure ~~employee~~financing, ~~compliance~~the ~~training 20. Establish board oversight of~~ Company’s ~~expenditures~~will fail.

~~Numbers~~Of 1the ~~through~~aforementioned 6reforms, ~~to date have not been implemented as~~ there has been noone ~~revenue~~new ~~generated~~independent ~~and~~Director ~~currently~~appointed, ~~the~~an ~~Company~~Audit ~~only~~Committee has ~~one~~been ~~employee. To date~~appointed, ~~Mr.~~consisting ~~Rountree~~solely ~~is funding the Company and there aren’t enough funds to implement all~~ of ~~the requirements of the Stipulation.~~ Mr. Mudd, ~~continues to monitor~~ the ~~progress~~existing ofcompensation ~~the~~plans ~~Company. Numbers 14 through 19~~ have ~~not yet~~ been ~~implemented; with regard to number 20~~terminated, ~~the~~all ~~Board~~dealing ~~discusses~~ with ~~Mr.~~third ~~Rountree~~party ~~the~~stock ~~expenses~~promoters ~~incurred~~has byceased, the Company’s atwebsite ~~board~~is ~~meetings. The~~being ~~agreement calls for the above to be completed within four years; however~~maintained, ~~the implementation of each remains at the discretion,~~ and ~~subject~~Counsel tohas ~~the~~been ~~judgement, of Mr~~engaged. ~~Mudd.~~ InThe ~~the~~remaining ~~event~~reforms ~~that~~will ~~the~~be ~~Company~~implemented ~~does~~and ~~not~~adopted ~~begin~~as tofunding ~~generate~~becomes ~~income,~~available orand ~~secure financing,~~ the Company ~~will~~begins ~~fail~~generating revenue.

OfOther ~~the~~than ~~aforementioned~~as ~~reforms,~~set ~~there~~out ~~has~~above, ~~been~~the Company ~~one~~knows ~~new~~of ~~independent~~no ~~Director appointed~~material, anexisting ~~Audit~~or ~~Committee~~pending ~~has~~legal ~~been~~proceedings ~~appointed~~against it, ~~consisting~~nor ~~solely~~is ~~of Mr. Mudd,~~ the ~~existing~~Company ~~compensation~~involved ~~plans~~as ~~have~~a ~~been~~plaintiff ~~terminated,~~in ~~all~~any ~~dealing~~material ~~with~~proceeding ~~third~~or ~~party~~pending ~~stock~~litigation. ~~promoters~~There ~~has~~are ~~ceased,~~no ~~the~~proceedings ~~Company’s~~in ~~website~~which isits ~~being maintained~~director, ~~and~~officer ~~Counsel~~or ~~has~~any ~~been~~affiliates, ~~engaged. The~~or ~~remaining~~any ~~reforms~~registered ~~will~~or bebeneficial ~~implemented~~shareholder, ~~and~~is ~~adopted~~an asadverse ~~funding~~party ~~becomes~~or ~~available~~has ~~and~~a ~~the~~material ~~Company~~interest ~~begins~~adverse ~~generating~~to ~~revenue~~its interest.

Table of Contents

At this time, Mr. Rountree, our CEO and CFO is funding the Company with his personal funds.

The Settlement additionally calls for 15% of revenue or financing raised by the Company to go toward the afore-mentioned governance reforms, along with compliance fees. To date, there haven’t been funds put aside as Mr. Rountree continues to personally fund the Company, including paying compliance fees.

Other than as set out above, the Company knows of no material, existing or pending legal proceedings against it, nor is the Company involved as a plaintiff in any material proceeding or pending litigation. There are no proceedings in which its director, officer or any affiliates, or any registered or beneficial shareholder, is an adverse party or has a material interest adverse to its interest.

ITEM 1A. RISK FACTORS

The Company is a smaller reporting company as defined by Rule 12b-2 of the Securities Exchange Act of 1934 and is not required to provide the information under this item.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no sales of equity securities during the period covered by this Report which have not been prior disclosed on Current Report on Form 8-K, Form 10-Q or Form 10-K.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY STANDARDS

Not applicable.

ITEM 5. OTHER INFORMATION

None.

Table of Contents

ITEM 6. EXHIBITS, FINANCIAL STATEMENT SCHEDULES

Exhibit Number		Exhibit Description
(31)		Rule 13a-14(a)/15d-14(a) Certifications
31*		Certification of our Chief Executive and Chief Financial Officer pursuant to Rule 13(a)-14(a)/15d-14(a) of the Securities Exchange Act of 1934, as amended
(32)		Section 1350 Certifications
32*		Certification of our Chief Executive and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes Oxley Act of 2002
101		The following financial statements from the Company’s Quarterly Report on Form 10-Q for the quarter ended October 31, 2023, formatted in Inline XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Operations (iii) Condensed Consolidated Statements of Stockholders’ Equity (Deficit), (iv) Condensed Consolidated Statements of Cash Flows, and (v) Notes to Condensed Consolidated Financial Statements, tagged as blocks of text and including detailed tags.
101.INS*		INLINE XBRL INSTANCE DOCUMENT (THE INSTANCE DOCUMENT DOES NOT APPEAR IN THE INTERACTIVE DATA FILE BECAUSE ITS XBRL TAGS ARE EMBEDDED WITHIN THE INLINE XBRL DOCUMENT)
101.SCH*		INLINE XBRL TAXONOMY EXTENSION SCHEMA
101.CAL*		INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF*		INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB*		INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE*		INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
104*		COVER PAGE INTERACTIVE DATA FILE (FORMATTED AS INLINE XBRL AND CONTAINED IN EXHIBIT 101)

*Filed herewith

Table of Contents

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		ECO SCIENCE SOLUTIONS, INC.
December 8, 2023		/s/ Michael Rountree
October 30, 2024		/s/ Michael Rountree
		CEO, CFO, COO, President, and Treasurer (Principal Executive Officer, Principal Financial and Accounting Officer)

Filing Compare · ECO SCIENCE SOLUTIONS, INC.